{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-087368","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.282645+00:00","generated_at":"2026-05-19T04:42:06.654304+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aptevo Therapeutics enters $25M standby equity purchase agreement with Yorkville","bullets":["Up to $25M in common stock may be sold to YA II PN over 36 months at 96% of lowest 3-day VWAP.","Exchange cap of 151,755 shares (19.99% of outstanding) unless stockholder approval or avg price ≥ $3.66.","Yorkville's beneficial ownership limited to 9.99% of outstanding shares.","Structuring fee of $25,000 paid; commitment fee of 2% of commitment amount in five quarterly installments.","Advance subject to filing and effectiveness of registration statement with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-087368","json":"https://secwatch.observer/filing/0000950170-25-087368.json","markdown":"https://secwatch.observer/filing/0000950170-25-087368.md","text":"https://secwatch.observer/filing/0000950170-25-087368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025087368/0000950170-25-087368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025087368/apvo-20250616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:42:06.654304+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}